The Journal of Organic Chemistry
Page 14 of 22
1
2
3
4
5
6
7
10H), 6.39 – 6.24 (m, 2H), 5.23 (dd, J = 5.8, 1.5 Hz, 1H), 5.19 – 5.06 (AB, m, 2H), 3.42 (s, 3H), 3.33 (d, J = 9.7 Hz, 1H), 3.11 (s,
3H), 2.88 (dt, J = 9.9, 2.7 Hz, 1H), 2.84 – 2.74 (m, 2H), 1.49 (dt, J = 13.2, 2.9 Hz, 1H). 13C NMR (DMSO-d6, 101 MHz, 398K): δ
170.2, 167.1, 154.1, 142.6, 136.5, 133.4, 130.5, 128.4, 127.7, 127.6, 127.0, 126.9, 126.8, 65.5, 59.1, 51.1, 49.2, 45.2, 33.1, 29.6. IR
(neat): ν =1737, 1680, 1652, 1638, 1496, 1441, 1417, 1405, 1247, 1215, 1130, 1122, 990, 732. HRMS (ES): m/z calcd. for
8
9
1
C25H27N2O5 435.1920 [M+H]+, found 435.1928. Isolated exo-5a, off-white semisolid. H NMR (DMSO-d6, 400 MHz, 378K): δ
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
7.43 – 7.25 (m, 8H), 7.16 – 7.10 (m, 2H), 6.51 (ddd, J = 7.7, 5.9, 1.5 Hz, 1H), 6.33 (ddd, J = 7.8, 6.5, 1.2 Hz, 1H), 5.15 (dd, J = 6.0,
1.2 Hz, 1H), 5.08 – 4.96 (AB, m, 2H), 3.47 (s, 3H), 3.18 – 3.08 (m, 1H), 3.07 (s, 3H), 2.86 – 2.75 (m, 2H), 2.16 (d, J = 13.1 Hz,
1H), 1.62 (dt, J = 13.0, 2.7 Hz, 1H). 13C NMR (DMSO-d6, 101 MHz, 378K): δ 170.5, 168.7, 153.6, 141.7, 136.5, 132.5, 131.9,
128.5, 127.7, 127.1, 127.1, 126.8, 124.3, 65.5, 60.2, 51.5, 51.0, 44.7, 37.8, 32.9, 29.6. IR (neat): ν = 1739, 1696, 1650, 1593, 1496,
1411, 1363, 1335, 1294, 1276, 1114. HRMS (ES): m/z calcd. for C25H27N2O5 435.1920 [M+H]+, found 435.1924.
2-Benzyl 6-methyl (1R*,4R*,6R*)-6-(diethylcarbamoyl)-2-azabicyclo[2.2.2]oct-7-ene-2,6-dicarboxylate (endo-5b) & 2-benzyl 6-
methyl (1R*,4R*,6S*)-6-(diethylcarbamoyl)-2-azabicyclo[2.2.2]oct-7-ene-2,6-dicarboxylate (exo-5b). According to GP1, N-Cbz-
1,2-dihydropyridine (350 mg, 1.63 mmol) and methyl 2-(diethylcarbamoyl)acrylate (4b, 100 mg, 0.54 mmol) were heated for 7 d.
FC purification (n-hexane:EtOAc 4:1 → 2:3) afforded a mixture of diastereoisomers endo-5b:exo-5b in a 58:42 ratio (120 mg,
50%). Isolated endo-5b, colourless paste. 1H NMR (DMSO-d6, 400 MHz, 378K): δ 7.45 – 7.25 (m, 5H), 6.48 – 6.36 (m, 2H), 5.22
– 5.18 (m, 1H), 5.11 – 4.97 (AB, m, 2H), 3.64 (s, 3H), 3.40 – 3.09 (m, 5H), 2.91 – 2.82 (m, 2H), 1.76 (br s, 1H), 1.06 – 0.92 (m,
6H). 13C NMR (DMSO-d6, 101 MHz, 398K): δ 171.3, 166.0, 154.0, 136.7, 134.1, 130.6, 127.7, 127.0, 126.8, 65.4, 58.5, 51.6, 49.0,
45.3, 32.6, 29.8, 11.81. IR (neat): ν = 2978, 2957, 1731, 1699, 1638, 1417, 1293, 1245, 1211, 1114, 736, 699. HRMS (ES): m/z
calcd. for C22H29N2O5 401.2076 [M+H]+, found 401.2082. Exo-5b not fully separated from endo-5b, pale yellow paste.
1
Distinguishable peaks only: H NMR (DMSO-d6, 400 MHz, 378K): δ 6.51 – 6.45 (m, 1H), 6.33 – 6.25 (m, 1H), 5.14 (dd, J = 6.0,
0.8 Hz, 1H), 3.52 (s, 3H), 1.45 (dt, J = 12.8, 2.7 Hz, 1H), 1.32 – 1.19 (m, 1H). Distinguishable peaks only: 13C NMR (DMSO-d6,
101 MHz, 378K): δ 171.5, 168.1, 153.7, 136.6, 132.9, 131.5, 127.7, 127.1, 65.6, 59.9, 51.8, 51.0, 30.3, 29.6, 21.3, 13.1.
2-Benzyl 6-methyl (1R*,4R*,6R*)-6-(diphenylcarbamoyl)-2-azabicyclo[2.2.2]oct-7-ene-2,6-dicarboxylate (endo-5c) & 2-benzyl 6-
methyl (1R*,4R*,6S*)-6-(diphenylcarbamoyl)-2-azabicyclo[2.2.2]oct-7-ene-2,6-dicarboxylate (exo-5c). According to GP1, N-Cbz-
1,2-dihydropyridine (467 mg, 2.17 mmol) and methyl 2-(diphenylcarbamoyl)acrylate (4c, 305 mg, 1.09 mmol) were heated for 6.5
h. FC purification (n-hexane:Et2O 3:2 → 3:7) afforded a mixture of diastereoisomers endo-5c:exo-5c in a 69:31 ratio (465 mg,
1
86%). Isolated endo-5c, white solid. MP = 140 – 141 °C. H NMR (DMSO-d6, 500 MHz, 398K): δ 7.45 – 7.20 (m, 15H), 6.37 –
6.30 (m, 1H), 6.30 – 6.24 (m, 1H), 5.33 (d, J = 5.3 Hz, 1H), 5.23 – 5.10 (AB, app q, 2H, J = 15.5 Hz), 3.41 (s, 3H), 3.39 – 3.33 (m,
1H), 2.93 (dt, J = 9.9, 2.6 Hz, 1H), 2.88 – 2.78 (m, 2H), 1.50 – 1.43 (dt, 1H, J = 16.5, 3.5 Hz). 13C NMR (DMSO-d6, 126 MHz,
398K) δ 169.7, 167.8, 154.4, 142.3, 136.4, 133.3, 130.6, 128.3, 128.0, 127.6, 127.0, 126.8, 126.6, 65.7, 59.8, 51.1, 49.6, 45.2, 33.4,
ACS Paragon Plus Environment
14